(Press-News.org) Researchers have uncovered that some childhood cancers have a substantially higher number of DNA changes than previously thought, changing the way we view children’s tumours and possibly opening up new or repurposed treatment options.
Concentrating on a type of childhood kidney cancer, known as Wilms tumour, an international team genetically sequenced multiple tumours at a resolution that was previously not possible. This collaboration included researchers at the Wellcome Sanger Institute, University of Cambridge, Princess Máxima Center for Pediatric Oncology, the Oncode Institute in the Netherlands, Great Ormond Street Hospital, and Cambridge University Hospitals NHS Foundation Trust.
They uncovered many more genetic changes per cancer cell than expected, adding up to millions of changes per tumour. This suggests that some childhood tumours could be eligible for treatments such as immunotherapy.
In the study, published today (29 May) in Nature Communications, the team also describes a single, spontaneous genetic change that causes a rare type of Wilms tumour, which children are born with, and that this change happens early during development in the womb. They found that these tumours have a particular appearance under the microscope and genetic profile, implying that it could be possible, in the future, to develop personalised therapeutics and tailor clinical plans for those with this genetic change.
This research challenges the widely held notion that childhood cancers have a very low number of genetic changes and instead suggests that there could be effective adult treatments that could be adapted for childhood tumours in the future.
Wilms tumour is a type of kidney cancer that largely affects children under the age of five. In the UK, about 85 children are diagnosed with Wilms tumour every year1.
Previously, it was thought that childhood cancer tumours, like those in Wilms tumour, had a low number of genetic changes, also called genetic variants.
To investigate how and why these tumours present so early in life, the team at the Sanger Institute and their collaborators applied the latest genomic sequencing techniques to understand more about how and when these genetic changes occurred.
Bulk whole genome sequencing methods allow researchers to find genetic changes that are shared by all the cells in the tumour. While this can work well for adult tumours, as the cells have had more time to develop, childhood tumours have fewer shared genetic changes, meaning that the large number of mutations that are not shared by all cells are missed.
To overcome this, the team used two cutting-edge techniques: nanorate sequencing2, otherwise known as nanoseq, and whole-genome sequencing of single-cell-derived organoids3 to study kidney tumours at much higher resolution. These methods allow scientists to find genetic changes that might be present in just a single cell of a cancer.
The team used these methods to genetically sequence Wilms tumour samples from four children, aged up to six months. They found that a single cancer cell had an additional 72 to 111 genetic changes on top of the ones already identified via bulk whole genome sequencing methods4. This means that when the overall number of cells in the tumour is taken into consideration, there are most likely millions of genetic changes per tumour overall, not the low numbers that were previously thought.
Alongside changing our understanding of childhood tumours, this new finding could also have implications for treatment. The researchers suggest that with this number of possible genetic changes, it’s likely that tumours could become resistant to treatments quicker, or that some drugs might not work at all.
However, this discovery could also mean that childhood tumours are better candidates for existing treatments that are currently used for adult tumours, such as immunotherapies5.
The team also traced the evolution of the tumours in three children and uncovered a new mutation that causes Wilms tumour. This single change in the FOXR2 gene was found to happen while the kidney was developing in the womb, and is associated with a particular appearance of the tumour under the microscope and a specific set of RNA changes. Researchers suggest that this could be used to identify these tumours and that, one day, it may be possible to develop specific personalised treatment for certain genetic profiles in Wilms tumour.
Dr Henry Lee-Six, co-first author at the Wellcome Sanger Institute, said: “Widespread sequencing methods are incredibly useful for a large number of cancer tumours, especially in adults. However, they fail to capture the true genetic complexity of cancers, particularly those that occur in the youngest children. With these latest genomic sequencing techniques, we can now see a much more detailed picture of Wilms tumour, which can occur in newborns. This could help us understand this condition in more detail, and may change the way we view and treat childhood tumours as a whole.”
Dr Jarno Drost, co-senior author at the Princess Máxima Center for Pediatric Oncology and the Oncode Institute in the Netherlands, said: “Being able to trace the evolution of a tumour can uncover crucial information about how and why it develops. In this study, we uncovered a single genetic change that occurred during development and caused this subset of Wilms tumour. Treatment for Wilms tumour has to carefully balance treating the tumour and lowering the risk of recurrence, while minimising the impact this can have on a young child’s quality of life and their family. By understanding the genetic changes that cause tumours, and in this case, identifying different genetic subsets, it could lead to more targeted treatment options, something that every child deserves.”
Professor Sam Behjati, co-senior author at the Wellcome Sanger Institute and Cambridge University Hospitals NHS Foundation Trust, said: “It has been a widely held belief that childhood tumours had much lower numbers of genetic changes than adult tumours. However, thanks to the development of new genomic sequencing tools, we have been able to show that, at least in these cases, it is not true. Our findings suggest that childhood tumours have at least four times more genetic changes per cell than expected, which adds millions more changes per tumour, highlighting that what we could see before was just the tip of the iceberg. This has implications for both childhood kidney cancer and possibly other childhood tumours. If we understand childhood cancer fully, we can develop new ways to treat it or repurpose existing treatments to get options to those who need them as quickly as possible.”
ENDS
Contact details:
Rachael Smith
Press Office
Wellcome Sanger Institute
Cambridge, CB10 1SA
07827979492 / 07748379849
Email: press.office@sanger.ac.uk
Notes to Editors:
Cancer Research UK. Wilms tumour (nephroblastoma) web page. Available at: https://www.cancerresearchuk.org/about-cancer/childrens-cancer/wilms-tumour/about [Last accessed: March 2025]
Nanorate sequencing is a new genomic sequencing method that attaches markers to both strands of DNA, compared to bulk sequencing methods that attach a marker to one of the strands. The two strands can be sequenced independently and the results compared. This allows for much more accurate sequencing, allowing the detection of extremely rare mutations.
Whole-genome sequencing of single-cell-derived organoids is a method where an organoid is grown from a single cell of a sample, meaning that all cells in the organoid share the set of genetic changes that were present in the original sampled cell. Whole-genome sequencing is then applied to the organoid to capture the genetic changes of a single cell.
Bulk whole genome sequencing of the tumours found between 30 and 61 genetic changes per tumour.
Immunotherapies harness the body's immune system to destroy the cancer cells, and can be very effective. A high amount of genetic changes is linked to the success of immunotherapy, and therefore, it was thought that many childhood tumours were not eligible.
Publication:
H. Lee-Six, T. D. Treger, M. Dave, et al. (2025) ‘High-resolution clonal architecture of hypomutated Wilms tumours’. Nature Communications. DOI: 10.1038/s41467-025-59854-4
Funding:
This research was part-funded by Wellcome, the Little Princess Trust, the European Research Council and a Dutch Cancer Society (KWF)/Alpe d’HuZes Bas Mulder Award. A full acknowledgement list can be found on the publication.
Selected websites:
The Wellcome Sanger Institute
The Wellcome Sanger Institute is a world leader in genomics research. We apply and explore genomic technologies at scale to advance understanding of biology and improve health. Making discoveries not easily made elsewhere, our research delivers insights across health, disease, evolution and pathogen biology. We are open and collaborative; our data, results, tools, technologies and training are freely shared across the globe to advance science.
Funded by Wellcome, we have the freedom to think long-term and push the boundaries of genomics. We take on the challenges of applying our research to the real world, where we aim to bring benefit to people and society.
Find out more at www.sanger.ac.uk or follow us on Twitter, Instagram, Facebook, LinkedIn and on our Blog.
About Wellcome
Wellcome supports science to solve the urgent health challenges facing everyone. We support discovery research into life, health and wellbeing, and we’re taking on three worldwide health challenges: mental health, infectious disease and climate and health. https://wellcome.org/
About the Princess Máxima Center for pediatric oncology
When a child is seriously ill from cancer, only one thing matters: a cure.
Every year, 600 children in the Netherlands are diagnosed with cancer. Sadly, one in four of these children dies. That is why in the Princess Máxima Center for pediatric oncology, we work together with passion and without limits every day to improve the survival rate and quality of life of children with cancer. Now, and in the long term. Because children have their whole lives ahead of them.
The Princess Máxima Center is no ordinary hospital, but a research hospital. All children with cancer in the Netherlands are treated here, and it’s where all research into childhood cancer in the country takes place. This makes the Princess Máxima Center the largest pediatric cancer center in Europe. More than 900 healthcare professionals and 450 scientists work closely with Dutch and international hospitals to find better treatments and new perspectives for a cure.
In this way, we offer children today the best possible care, and we take important steps to improve survival for children who cannot not yet be cured.
END
Childhood kidney cancer has millions of genetic changes, opening door to possible treatments
2025-05-29
ELSE PRESS RELEASES FROM THIS DATE:
‘Stealthy’ lipid nanoparticles give mRNA vaccines makeover
2025-05-29
ITHACA, N.Y. – A new material developed at Cornell University could significantly improve the delivery and effectiveness of mRNA vaccines by replacing a commonly used ingredient that may trigger unwanted immune responses in some people.
Thanks to their ability to train cells to produce virus-killing proteins, mRNA vaccines have gained popularity over the last five years for their success in reducing the severity of COVID-19 infection. One method for delivering the mRNA to cells is by packaging it inside fatty spheres, called lipid nanoparticles, that protect it from being degraded. However, a common component of ...
Atlantic ocean current unlikely to collapse with climate change
2025-05-29
The Atlantic meridional overturning circulation, commonly referred to as the “AMOC,” is a system of ocean currents confined to the Atlantic basin that plays a crucial role in regulating Earth’s climate by transporting heat from the Southern to the Northern Hemisphere. The AMOC also modulates regional weather, from the mild summers in Europe to the monsoon seasons in Africa and India. Climate models have long predicted that global warming will cause the AMOC to weaken, with some projecting substantial weakening ...
MISTRAL, a wind of change in the SRT observations
2025-05-29
MISTRAL is a new generation receiver installed on the Sardinia Radio Telescope (SRT) and built by the Sapienza University of Rome for the National Institute for Astrophysics (INAF) as part of the upgrade of the radio telescope for the study of the Universe at high frequencies, funded by a PON (National Operational Program) project, concluded in 2023 and now providing its first significant scientific results. MISTRAL stands for “MIllimetric Sardinia radio Telescope Receiver based on Array of Lumped elements kids”.
MISTRAL is an innovative receiver in many ways. Radio astronomy ...
Report: ‘Future-proofing’ crops will require urgent, consistent effort
2025-05-29
CHAMPAIGN, Ill. — In a review in The Philosophical Transactions of the Royal Society B, Stephen Long, a professor of crop sciences and of plant biology at the University of Illinois Urbana-Champaign, describes research efforts to “future-proof” the crops that are essential to feeding a hungry world in a changing climate. Long, who has spent decades studying the process of photosynthesis and finding ways to improve it, provides an overview of key scientific findings that offer a ray of hope.
Higher temperatures, more frequent and longer droughts, catastrophic rainfall events and rising atmospheric carbon dioxide levels all ...
Diagnostics.AI launches industry’s first CE-IVDR certified transparent AI platform for molecular diagnostics as regulatory deadlines take fffect
2025-05-29
LONDON, England
Revolutionary Platform Sets New Benchmark for Transparency and Compliance in Diagnostic AI
As the May 26th CE-IVDR compliance deadline comes into effect, Diagnostics.ai launches the industry’s first fully-transparent machine learning platform for clinical real-time PCR diagnostics – demonstrating exactly how each result was achieved, a first for molecular-testing machine learning. The technology is backed by over 15 years of experience and millions of successfully processed samples with >99.9% proven accuracy.
The CE-IVDR Strategic Advantage Platform is Diagnostics.ai's ...
Could ‘pausing’ cell death be the final frontier in medicine on Earth and beyond?
2025-05-29
The process of necrosis, a form of cell death, may represent one of the most promising ways to change the course of human aging, disease and even space travel, according to a new study from researchers at UCL, drug discovery company LinkGevity and the European Space Agency (ESA).
In the study, published in Nature Oncogene, a world-leading international team of scientists and clinicians explore the potential of necrosis – when cells die unexpectedly as a result of infection, injury or disease – to reshape our understanding and treatment of age-related conditions.
Challenging prevailing ...
New research shows importance of promoting better understanding and inclusion of children with disabilities in the classroom
2025-05-29
According to the National Center on Birth Defects and Developmental Disabilities, approximately 1 in 6 children in the United States have developmental disabilities which include physical, learning, language or behavior-related disabilities. Students with disabilities often receive accommodations (how students access and learn the same content as their classmates) at school, but teachers rarely explain them to typically-developing classmates. Children with disabilities are increasingly included in general education classrooms alongside typically-developing classmates. Accommodations ...
World record achieved in transmission capacity and distance: With 19-core optical fiber with standard cladding diameter 1,808 km transmission of 1.02 petabits per second
2025-05-29
Highlights
- The world's first successful petabit-class transmission over more than 1,000 km using standard 19-core optical fiber, achieving a transmission rate of 1.02 petabits per second over a distance of 1,808 km.
- Achieved using a newly developed standard 19-core optical fiber, equivalent to 19 standard fibers, low loss across multiple wavelength bands, and the development of an optical amplification relay function compatible with this fiber.
- This is a major step to realize future long-distance, large-capacity optical communication systems.
Abstract
An international research team led by the Photonic Network Laboratory at the National Institute of Information and ...
Sharks rarely seen together may be up for sharing a meal too good to miss
2025-05-29
Many sharks, particularly those that live in the open oceans, are hunters rather than scavengers. Despite this, a small portion of their diet comes from scavenging, a behavior they may engage in when the opportunity arises.
Now, writing in Frontiers in Fish Science, researchers have described an unusual aggregation of sharks coming together to feed on a carcass that had decayed to mostly flesh and blubber.
“To our knowledge, this is the first study to document a feeding aggregation of tiger sharks and oceanic whitetip sharks scavenging concurrently, and peacefully, on a carcass,” said first author Dr Molly Scott, a marine researcher ...
Borders and beyond: Excavating life on the medieval Mongolian frontier
2025-05-28
New archaeological findings along a little-known medieval wall in eastern Mongolia reveal that frontier life was more complex than previously believed. Excavations show evidence of permanent habitation, agriculture, and cultural exchange, suggesting that these walls were not solely defensive structures but part of a broader system of regional control and interaction during the Jin dynasty.
Link to pictures and video: https://drive.google.com/drive/folders/1krCqKwVHzMIA-EaU7AhES47HikEgElmp?usp=sharing
A team of international archaeologists ...